Ehsan Bahramali

1.6k total citations
44 papers, 554 citations indexed

About

Ehsan Bahramali is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ehsan Bahramali has authored 44 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 15 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ehsan Bahramali's work include Hormonal Regulation and Hypertension (9 papers), Renin-Angiotensin System Studies (6 papers) and Cardiovascular Function and Risk Factors (5 papers). Ehsan Bahramali is often cited by papers focused on Hormonal Regulation and Hypertension (9 papers), Renin-Angiotensin System Studies (6 papers) and Cardiovascular Function and Risk Factors (5 papers). Ehsan Bahramali collaborates with scholars based in Iran, United States and United Kingdom. Ehsan Bahramali's co-authors include Negar Firouzabadi, Mojtaba Farjam, Reza Homayounfar, Javad Jamshidi, Massoumeh Shafiei, Alireza Askari, Hossein Poustchi, Hooman Bakhshandeh, Nader Tajik and Alireza Tavassoli and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Ehsan Bahramali

42 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ehsan Bahramali Iran 14 189 133 106 78 54 44 554
Maddalena Ardissino United Kingdom 16 219 1.2× 100 0.8× 56 0.5× 61 0.8× 70 1.3× 60 779
Owais Khawaja United States 16 271 1.4× 79 0.6× 169 1.6× 60 0.8× 80 1.5× 26 641
Carolina Restini Brazil 17 180 1.0× 47 0.4× 84 0.8× 108 1.4× 60 1.1× 51 622
Suttira Intapad United States 15 68 0.4× 63 0.5× 77 0.7× 106 1.4× 26 0.5× 29 762
Andy Kim United States 4 190 1.0× 63 0.5× 72 0.7× 86 1.1× 27 0.5× 10 402
Yutao Lan China 11 60 0.3× 86 0.6× 48 0.5× 65 0.8× 45 0.8× 21 400
N.T. Malan South Africa 17 399 2.1× 138 1.0× 127 1.2× 136 1.7× 129 2.4× 36 871
M. Reimann Germany 14 93 0.5× 177 1.3× 41 0.4× 110 1.4× 72 1.3× 31 491
Janice Campbell United States 14 53 0.3× 64 0.5× 113 1.1× 67 0.9× 39 0.7× 33 617
Cornelia Bala Romania 13 116 0.6× 229 1.7× 101 1.0× 128 1.6× 110 2.0× 57 645

Countries citing papers authored by Ehsan Bahramali

Since Specialization
Citations

This map shows the geographic impact of Ehsan Bahramali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehsan Bahramali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehsan Bahramali more than expected).

Fields of papers citing papers by Ehsan Bahramali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ehsan Bahramali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehsan Bahramali. The network helps show where Ehsan Bahramali may publish in the future.

Co-authorship network of co-authors of Ehsan Bahramali

This figure shows the co-authorship network connecting the top 25 collaborators of Ehsan Bahramali. A scholar is included among the top collaborators of Ehsan Bahramali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ehsan Bahramali. Ehsan Bahramali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Homayounfar, Reza, Mojtaba Farjam, Ehsan Bahramali, et al.. (2023). Cohort Profile: The Fasa Adults Cohort Study (FACS): a prospective study of non-communicable diseases risks. International Journal of Epidemiology. 52(3). e172–e178. 33 indexed citations
3.
Firouzabadi, Negar, et al.. (2020). Carvedilol Alters Circulating MiR-1 and MiR-214 in Heart Failure. SHILAP Revista de lepidopterología. 2 indexed citations
4.
Firouzabadi, Negar, et al.. (2020). <p>Overexpression of Adiponectin Receptors in Opium Users with and without Cancer</p>. Clinical Pharmacology Advances and Applications. Volume 12. 59–65. 2 indexed citations
5.
Firouzabadi, Negar, et al.. (2020). <p>Carvedilol Alters Circulating MiR-1 and MiR-214 in Heart Failure</p>. Pharmacogenomics and Personalized Medicine. Volume 13. 375–383. 12 indexed citations
6.
Seif, Mozhgan, et al.. (2020). The dynamics of metabolic syndrome development from its isolated components among iranian children and adolescents: Findings from 17 Years of the Tehran Lipid and Glucose Study (TLGS). Diabetes & Metabolic Syndrome Clinical Research & Reviews. 15(1). 99–108. 2 indexed citations
7.
Firouzabadi, Negar, et al.. (2020). <p>Biomarkers of IL-33 and sST2 and Lack of Association with Carvedilol Therapy in Heart Failure</p>. Clinical Pharmacology Advances and Applications. Volume 12. 53–58. 6 indexed citations
8.
Shahraki, Hadi Raeisi, Mojtaba Farjam, Ehsan Bahramali, et al.. (2020). Dietary inflammatory index and metabolic syndrome in Iranian population (Fasa Persian Cohort Study). Scientific Reports. 10(1). 16762–16762. 16 indexed citations
9.
Zibaeenezhad, Mohammad Javad, Haleh Ghaem, Mehrab Sayadi, et al.. (2019). Analysing cardiovascular risk factors and related outcomes in a middle-aged to older adults population in Iran: a cohort protocol of the Shiraz Heart Study (SHS). BMJ Open. 9(4). e026317–e026317. 14 indexed citations
10.
Zibaeenezhad, Mohammad Javad, et al.. (2019). The impact of diabetes mellitus and hypertension on clinical outcomes in a population of Iranian patients who underwent percutaneous coronary intervention: A retrospective cohort study. Journal of Clinical Hypertension. 21(11). 1647–1653. 10 indexed citations
12.
Sarvestani, Raheleh Sabet, et al.. (2017). Challenges of Family Physician Program in Urban Areas: A Qualitative Research.. PubMed. 20(7). 446–451. 16 indexed citations
14.
Firouzabadi, Negar, et al.. (2017). Beta Adrenoceptor Polymorphism and Clinical Response to Sertraline in Major Depressive Patients. Journal of Pharmacy & Pharmaceutical Sciences. 20. 1–1. 12 indexed citations
15.
Bahramali, Ehsan, et al.. (2016). Association of ACE gene D polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: a case–control study. BMJ Open. 6(2). e010282–e010282. 31 indexed citations
16.
Bahramali, Ehsan, et al.. (2016). Caregivers Awareness about the rules of Family Physician Program in Fasa in the Year 2014. SHILAP Revista de lepidopterología. 6(3). 326–333. 1 indexed citations
17.
Askari, Alireza, et al.. (2015). Metabolic Syndrome as a Risk Factor for Osteoarthritis. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Bahramali, Ehsan, et al.. (2014). Investigating the Consistancy Rate of Hypertension Treatment through Guide Line JNC-7, in Patients Who Were Referred to Health Centers and Health Houses of Fasa University of Medical Sciences 2012. SHILAP Revista de lepidopterología. 4 indexed citations
19.
Haghjoo, Majid, et al.. (2012). Value of the aVR lead in differential diagnosis of atrioventricular nodal reentrant tachycardia. EP Europace. 14(11). 1624–1628. 9 indexed citations
20.
Bahramali, Ehsan, Negar Firouzabadi, H Salahi, et al.. (2005). Neurological Complications of First 100 Orthotopic Liver Transplantation Patients in Southern Iran. Transplantation Proceedings. 37(7). 3197–3199. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026